Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
James Udelson MD

James E. Udelson MD

Chief, Division of Cardiology; Director, Nuclear Cardiology Laboratory, Tufts Medical Center; Professor, Medicine and Radiology, Tufts University School of Medicine, Boston, Massachusetts

Dr. James Udelson is Chief of the Division of Cardiology as well as Director of Nuclear Cardiology at Tufts Medical Center. He is a Professor of Medicine and Radiology at Tufts University School of Medicine in Boston.

He has been the recipient of several NIH grants for studies of the use of cardiac imaging to better understand the physiology of left ventricular function and to favorably influence clinical decision–making. He has directed and/or participated in numerous clinical trials on heart failure and cardiac imaging, focusing on the role of new therapies and how they affect remodeling, physiology, function, and outcomes.

Dr. Udelson has been involved in editorial capacities for several high-impact journals including Circulation, Circulation: Heart Failure, JAMA Cardiology, the Journal of the American College of Cardiology (JACC), and the Journal of Nuclear Cardiology, among others, and has served on numerous national guideline and appropriate-use criteria writing groups. He has participated in a leadership capacity for professional organizations including the American Society of Nuclear Cardiology, the American College of Cardiology (ACC), and the Heart Failure Society of America. Additionally, he has served on several FDA advisory panels.

Disclosures

  • Advisory boards/trial committees: Bayer; MedTrace; LivaNova; scPharmaceuticals; Cardurion; Imbria; Abiomed; Merck; Cytokinetics; Medtronic; Reprieve Cardiovascular; Alleviant Medical

Recent Contributions to PracticeUpdate:

  1. Nomogram Utilizing Coronary Artery Calcium Scoring Predicts 5-, 10-, and 15-Year Survival
  2. Carotid Plaque Lipid Content and Fibrous Cap Status Predict Systemic CV Outcomes
  3. Coronary Artery Calcium in Younger Adults Associated With Subsequent Coronary Heart Disease and Death
  4. Characterizing Functional Tricuspid Regurgitation Caused by Chronic Atrial Fibrillation
  5. 2016 Top Stories in Cardiology: Out of the Mothballs: Tc 99m Imaging for Diagnosis of Cardiac Amyloid
  6. Left Atrial Emptying Fraction Is a Powerful Predictor of Incident Cardiovascular Events
  7. Coronary Atherosclerosis T1-Weighed Characterization With Integrated Anatomical Reference
  8. Quantification of Lipid-Rich Core in Carotid Atherosclerosis Using CMR T2 Mapping
  9. Optical Coherence Tomography Optimizes Results in PCI
  10. Prognostic Implications of LV Strain Risk Score in Asymptomatic Hypertensive Heart Disease

Most Read This Week

Recently Updated